February 19, 2014
Posted January 22, 2016
Medical device manufacturer EndoGastric Solutions agreed to pay up to $5.25M to resolve allegations that it violated the False Claims Act by misleading health care providers about how to bill federal health care programs for a procedure using a device manufactured by the company and by paying kickbacks. The allegations were first raised in a qui tam lawsuit filed under the whistleblower provisions of the False Claims Act. DOJ
Tagged in: FCA Federal, Medical Billing Fraud, Medical Devices and DME, Whistleblower Case,